段以下肺动脉栓子位置及栓塞程度对肺灌注减低的影响

来源 :河北医药 | 被引量 : 0次 | 上传用户:cai67716029
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的应用能谱CT分析亚段栓子位置及栓塞程度对肺灌注减低发生率及程度影响。方法 26例可疑肺动脉栓塞患者行能谱CT肺动脉CTA检查,选取无段及段以上动脉栓塞病例,观察肺动脉内有无栓子,根据栓塞程度分为轻度(<50%)、重度(≥50%)、闭塞3组,观察是否存在灌注减低,并测量灌注减低区及相邻或对侧肺正常区碘含量。结果符合条件肺栓塞患者14例中,共有亚段栓子116个,其中5级78个,6级26个,7级及以下12个。上述3组存在重度以上栓塞的构成比分别为71.8%、73.1%、100%,7级及以下组较第5、6级组构成比高(P<0.01),3组存在碘灌注减低的构成比分别为37.2%、38.5%、83.3%,第7级及以下组较第5、6级高(P=0.01)。在栓塞程度与灌注减低关系上,29个栓子狭窄程度<50%,64个≥50%,23个栓子为闭塞,相应区域碘灌注减低构成比分别为0、40.7%、100%,两两比较差异均有统计学意义(P<0.01);正常肺实质区与栓塞区碘含量差异有显著性(P=0.000);栓塞≥50%组与闭塞组灌注减低程度差异无显著性(P=0.43)。结论在亚段栓塞中,肺灌注减低发生率及减低程度与栓子位置及其栓塞程度密切相关,第7级及以下肺动脉发生重度以上栓塞比例较高,更易导致灌注减低。 Objective To analyze the impact of sub-segment embolism and embolism on the incidence and extent of lung perfusion by using energy spectrum computed tomography (CT). Methods Twenty - six patients with suspicious pulmonary embolism were examined by spectral CT pulmonary angiography (CTA). The patients with or without arterial embolism were selected to observe the presence or absence of emboli in the pulmonary artery. According to the extent of embolism, they were divided into mild (<50%), severe %). The three groups were occluded to observe whether there was perfusion reduction and the iodine content in the normal zone of perfusion-reduced area and the adjacent or contralateral lung were measured. Results Among the 14 patients who met the criteria of pulmonary embolism, there were 116 sub-segments of emboli, of which 5 were 78, 6 were 26, 7 and below 12. The proportions of severe thromboembolism in the three groups were 71.8%, 73.1%, 100% respectively. The ratios of the constituent ratios of grade 7 and group were higher than that of the grade 5 and 6 (P <0.01) (37.2%, 38.5% and 83.3% respectively), while those in the seventh grade and the following groups were higher than the fifth and sixth grades (P = 0.01). In the relationship between embolization and perfusion reduction, 29 emboli were less than 50%, 64 were more than 50%, and 23 emboli were occluded. The I / R ratio in the corresponding area was 0, 40.7% and 100%, respectively There was a significant difference between two groups (P <0.01). There was a significant difference in iodine content between the parenchyma area and the embolic area (P = 0.000). There was no significant difference between the embolization group and the occlusion group = 0.43). Conclusions In the sub-embolization, the incidence and extent of pulmonary perfusion decrease are closely related to the location of the embolus and the degree of embolization. There is a high proportion of embolism in the pulmonary artery of grade 7 and below, which may lead to the decrease of perfusion.
其他文献
目的:探讨磷酸西格列汀联合甘精胰岛素治疗老年2型糖尿病(T2DM)的疗效,为临床治疗提供相应依据。方法:收集宝鸡市中心医院2011年12月至2013年12月82例老年T2DM患者作为研究对
利拉鲁肽(liraglutide,商品名SAXENDA)是由丹麦诺和诺德公司研制的用于肥胖治疗的人胰高血糖素样肽-1(GLP-1)类似物。至2014年12月,FDA批准作为治疗慢性肥胖的药物后,2015年1
Qsymia是由美国Vivus公司开发的新型复方减肥药,2012年7月17日,美国FDA批准其作为节食和锻炼疗法的辅助治疗药,适用对象为体质指数(BMI)为30及以上或27及以上且患有与体重相关
目的探讨程序性死亡受体(PD)-1单克隆抗体治疗肝细胞癌(肝癌)肝移植术后复发的安全性。方法回顾性分析1例因使用PD-1单克隆抗体(pembrolizumab)治疗肝癌肝移植后复发而诱发急
移植肾缺血-再灌注损伤(IRI)可引起移植肾功能延迟恢复、移植肾原发性无功能、急性排斥反应甚至导致移植肾丢失,是影响移植肾早期肾功能恢复和长期存活的重要因素。本文从缩短供
慢性移植物抗宿主病(cGVHD)是异基因造血干细胞移植(allo-HSCT)的主要后期并发症,严重影响患者的生存质量,是导致非复发性死亡的重要原因。cGVHD 的治疗一直是移植领域研究的重要内
近年来移植后糖尿病(PTDM)越来越受到人们的关注和重视。PTDM发生率较高,多发于术后早期,其后呈下降趋势,该病发展具有可逆性。目前 PTDM的诊断标准尚未统一,多采用世界卫生组织和
正电子发射断层(PET)显像可以活体、无创反映疾病的特征分子改变,如利用~(18)氟-脱氧葡萄糖(~(18)F-FDG)反映肿瘤的葡萄糖代谢,以及利用~(18)氟-硝基咪唑(~(18)F-FMISO)反映
目的:评价新辅助化疗(NAC)前18F-FDG PET/CT检查提高乳腺癌术后危险分组并对术后放疗的指导价值.方法:2009年7月至2013年5月一共收集乳腺癌患者309例,纳入研究224例.所有患者
通过总结、整理古今医家及临床实践经验进行编写,遵循继承性、科学性、严谨性、实践性原则,编写《周围血管科常见疾病证候诊治指南(2015)》,预期达到对临床上常见的周围血管疾病建